Maternal	maternal	O	O
lithium	lithium	S_chemicals	O
and	and	O	O
neonatal	neonatal	O	O
Ebstein	ebstein	O	B_disease
's	's	O	I_disease
anomaly	anomaly	O	I_disease
:	:	O	O
evaluation	evaluation	O	O
with	with	O	O
cross-sectional	cross-sectional	O	O
echocardiography	echocardiography	O	O
.	.	O	O

Cross-sectional	cross-sectional	O	O
echocardiography	echocardiography	O	O
was	was	O	O
used	used	O	O
to	to	O	O
evaluate	evaluate	O	O
two	two	O	O
neonates	neonates	O	O
whose	whose	O	O
mothers	mothers	O	O
ingested	ingested	O	O
lithium	lithium	S_chemicals	O
during	during	O	O
pregnancy	pregnancy	O	O
.	.	O	O

In	in	O	O
one	one	O	O
infant	infant	O	O
,	,	O	O
Ebstein	ebstein	O	B_disease
's	's	O	I_disease
anomaly	anomaly	O	I_disease
of	of	O	O
the	the	O	O
tricuspid	tricuspid	O	B_disease
valve	valve	O	I_disease
was	was	O	O
identified	identified	O	O
.	.	O	O

In	in	O	O
the	the	O	O
other	other	O	O
infant	infant	O	O
cross-sectional	cross-sectional	O	O
echocardiography	echocardiography	O	O
provided	provided	O	O
reassurance	reassurance	O	O
that	that	O	O
the	the	O	O
infant	infant	O	O
did	did	O	O
not	not	O	O
have	have	O	O
Ebstein	ebstein	O	B_disease
's	's	O	I_disease
anomaly	anomaly	O	I_disease
.	.	O	O

Cross-sectional	cross-sectional	O	O
echocardiographic	echocardiographic	O	O
screening	screening	O	O
of	of	O	O
newborns	newborns	O	O
exposed	exposed	O	O
to	to	O	O
lithium	lithium	S_chemicals	O
during	during	O	O
gestation	gestation	O	O
can	can	O	O
provide	provide	O	O
highly	highly	O	O
accurate	accurate	O	O
,	,	O	O
noninvasive	noninvasive	O	O
assessment	assessment	O	O
of	of	O	O
the	the	O	O
presence	presence	O	O
or	or	O	O
absence	absence	O	O
of	of	O	O
lithium-induced	lithium-induced	O	O
cardiac	cardiac	O	O
malformations	malformations	O	O
.	.	O	O

